AIM listed Tekcapital is an international provider of technology and intellectual property investment services. The company’s objective is to create value from investing in new, university-developed intellectual properties and to produce returns through capital appreciation.
Numbers for the 12 months to 30th November 2018 showed a 28% rise in revenue from services to $1.04 million. This came on the back of expansion into the Latin American markets and the launch of two new services, technology commercialisation training and an Invention Evaluator report customised for startups. The goal remains to have all operating costs covered by service revenues in the next few years.
The highlight of the year in our view was the 51% increase in net assets to a record level of $16.13 million. The main driver of the increase in NAV for the period was an 88% increase in the value of the company’s investment portfolio, from $7.31 million to $13.7 million.
Across the investment portfolio, Tekcapital saw its investee companies make further commercial progress and strengthen their management teams in 2018. Into 2019, several companies are expecting to see further milestones including Belluscura receiving 510(K) clearance from the FDA for its POC system in Q3, Lucyd launching further hi-tech products in Q2 and Salarius expected to start selling low sodium salt and snacks in Q4.
Despite the progress made, Tekcapital shares currently trade at near all time lows. At the current price of 7.25p the company is capitalised at just £3.94 million, a massive 68% discount to NAV of £12.34 million (equivalent to 22.96p per share), 217% above the current price, which we set as our new target price and remain with our Conviction Buy stance.